Literature DB >> 20876637

Head and neck cancer--Part 2: Treatment and prognostic factors.

H Mehanna1, C M L West, C Nutting, V Paleri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20876637     DOI： 10.1136/bmj.c4690

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  26 in total

1.  Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging.

Authors:  I Hwang; S H Choi; Y-J Kim; K G Kim; A L Lee; T J Yun; J-h Kim; C-H Sohn
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-27       Impact factor: 3.825

2.  Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.

Authors:  Arron Sikka; Manjinder Kaur; Chapla Agarwal; Gagan Deep; Rajesh Agarwal
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

3.  Optical pre-screening for laryngeal cancer using reflectance spectroscopy of the buccal mucosa.

Authors:  Oisín Bugter; Jose A Hardillo; Robert J Baatenburg de Jong; Arjen Amelink; Dominic J Robinson
Journal:  Biomed Opt Express       Date:  2018-09-06       Impact factor: 3.732

4.  Improved overall survival in head and neck cancer patients after specific therapy of distant metastases.

Authors:  Dominik Schulz; Markus Wirth; Guido Piontek; Andreas Knopf; Christoph Straube; Steffi Pigorsch; Stephanie E Combs; Anja Pickhard
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-08       Impact factor: 2.503

5.  Expression of stefin A is of prognostic significance in squamous cell carcinoma of the head and neck.

Authors:  Aleksandar Aničin; Nina Gale; Lojze Smid; Janko Kos; Primož Strojan
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-02       Impact factor: 2.503

6.  Comparable molecular alterations in 4-nitroquinoline 1-oxide-induced oral and esophageal cancer in mice and in human esophageal cancer, associated with poor prognosis of patients.

Authors:  Zhengduo Yang; Baoxiang Guan; Taoyan Men; Junya Fujimoto; Xiaochun Xu
Journal:  In Vivo       Date:  2013 Jul-Aug       Impact factor: 2.155

7.  The contribution of neck dissection for residual neck disease after chemoradiotherapy in advanced oropharyngeal and hypopharyngeal squamous cell carcinoma patients.

Authors:  Masahiro Suzuki; Daisuke Kawakita; Nobuhiro Hanai; Hitoshi Hirakawa; Taijiro Ozawa; Akihiro Terada; Koichi Omori; Yasuhisa Hasegawa
Journal:  Int J Clin Oncol       Date:  2012-05-16       Impact factor: 3.402

Review 8.  The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas.

Authors:  Eleni Benson; Ryan Li; David Eisele; Carole Fakhry
Journal:  Oral Oncol       Date:  2013-10-14       Impact factor: 5.337

9.  Weight loss in patients with head and neck cancer during and after conventional and accelerated radiotherapy.

Authors:  Sandra Ottosson; Björn Zackrisson; Elisabeth Kjellén; Per Nilsson; Göran Laurell
Journal:  Acta Oncol       Date:  2012-10-29       Impact factor: 4.089

10.  Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes.

Authors:  Vonn Walter; Xiaoying Yin; Matthew D Wilkerson; Christopher R Cabanski; Ni Zhao; Ying Du; Mei Kim Ang; Michele C Hayward; Ashley H Salazar; Katherine A Hoadley; Karen Fritchie; Charles J Sailey; Charles G Sailey; Mark C Weissler; William W Shockley; Adam M Zanation; Trevor Hackman; Leigh B Thorne; William D Funkhouser; Kenneth L Muldrew; Andrew F Olshan; Scott H Randell; Fred A Wright; Carol G Shores; D Neil Hayes
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.